Original Article

Human Wharton’s Jelly Mesenchymal Stem Cells Improve Insulin Levels and Reduce Weight Gain in Aging Female Rats

Abstract

Background: This study aimed to analyze the effect of repeated intravenous injections of human Wharton's jelly mesenchymal stem cells (hWJ-MSCs), administered at a dose of 1 × 10⁶ cells/kg four times at 3-month intervals, on insulin levels and weight gain in aging female rats.

Materials and Methods: Twelve female rats were divided into three groups: Group A (3-month-old young females, untreated control), Group B (24-month-old aged females injected with 0.4 mL of 0.9% NaCl as vehicle control), and Group C (24-month-old aged females injected with 1 × 10⁶ cells/kg of hWJ-MSCs suspended in 0.4 mL of 0.9% NaCl). Injections were administered at baseline and then every 3 months for a total of four doses. Twelve months after the first injection, the rats were anesthetized and sacrificed. Serum insulin levels were measured using ELISA, and immunohistochemical staining was performed to detect hWJ-MSCs homing to pancreatic tissue.

Results: Rats treated with hWJ-MSCs showed a trend toward lower body weight compared to the aged vehicle-control group. Insulin levels in treated aged rats were significantly higher than those in the aged control group (p < 0.05). Immunohistochemical analysis revealed that hWJ-MSCs were extensively distributed within the islets of Langerhans of treated aged rats.

Conclusion: Repeated intravenous administration of hWJ-MSCs (1 × 10⁶ cells/kg, four doses over 12 months) led to successful migration and homing to the islets of Langerhans in aging female rats. Treated animals exhibited significantly increased insulin levels and a trend toward reduced weight gain, suggesting a potential metabolic benefit of hWJ-MSC therapy in physiological aging.

1. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408(6809): 239-247.
2. Weindruch R, Sohal RS. Caloric intake and aging. N Engl J Med. 1997 Oct 2;337(14):986–994.
3. Hughes VA, Frontera WR, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci. 2001;56(5):B209-17.
4. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404-11.
5. Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ. 2015:6:14.
6. Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int. 2014:2014:757461.
7. Liu T, Huang Y, Zhang J, et al. Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse models. Stem Cells Dev. 2014;23(13):1548-57.
8. Fu X, He Y, Wang X, et al. Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. Stem Cell Res Ther. 2017. 8(1): 187.
9. Hwa KK, Ah LK. Metabolic Rewiring by Human Placenta-Derived Mesenchymal Stem Cell Therapy Promotes Rejuvenation in aged Female Rats. Int J Mol Sci. 2022;23(1):566.
10. Li X, Bai J, Ji X, et al. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med. 2014; 34(3): 695-704.
11. Astini W, Iman AF, Utami A, et al. Histomorphology of Pancreatic Islet in Physiological Aging Female Rats Post Intravenous Human Wharton’s Jelly Mesenchymal Stem Cell Injection. JSCRTE. 2019; 3(1): 6–11.
12. Li H, Zhirong Z, Shibo Z, et al. The Effects of Umbilical Cord Mesenchymal Stem Cells on Traumatic Pancreatitis in Rats. Dig Dis Sci. 2023; 68(1):147-154.
13. Yousef HN, Sakr SM, Sabry SA. Mesenchymal Stem Cells Ameliorate Hyperglycemia in Type I Diabetic Developing Male Rats. Stem Cells Int. 2022; 13:7556278.
14. Andreollo NA, Santos EF, Araújo MR, et al. Rat's age versus human's age: what is the relationship?. Arq Bras Cir Dig. 2012; 25(1):49-51.
15. Guo S, Zhang Y, Zhang Y, et al. Multiple Intravenous Injections of Valproic Acid-Induced Mesenchymal Stem Cell from Human-Induced Pluripotent Stem Cells Improved Cardiac Function in an Acute Myocardial Infarction Rat Model. BioMed Res Int. 2020; 2020:863501.
16. Widowati W, Wijaya L, Bachtiar I, et al. Effect of oxygen tension on proliferation and characteristics of Wharton’s jellyderived mesenchymal stem cells. Biomarkers Genomic Med. 2014; 6(1):43-48.
17. Weir GC, Aguayo-Mazzucato C, Bonner-Weir S. β-cell dedifferentiation in diabetes is important, but what is it?. Islets. 2013;5(5):233–237.
18. El-Hossary N, Hassanein H, El–Ghareeb AW, et al. Intravenous vs intraperitoneal transplantation of umbilical cord mesenchymal stem cells from Wharton’s jelly in the treatment of streptozotocin induced diabetic rats. Diabetes Res Clin Pract. 2016:121:102-111.
19. Reaven EP, Curry DL, Reaven GM. Effect of Age and Sex on Rat Endocrine Pancrease. Diabetes. 1987; 36(12):1397-1400.
20. Konovalov S, Moroz V, Konovalova N, et al. The effect of mesenchymal stromal cells of various origins on mortality and neurologic deficit in acute cerebral ischemia-reperfusion in rats. Cell Organ Transpl. 2021. 9(2):104-108.
21. Afifi NM. Effect of mesenchymal stem cell therapy on recovery of streptozotocin induced diabetes mellitus in adult male albino rats: a histological and immunohistochemical study. Egypt J Histol. 2012; 35:458–69
22. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108(7):863–8.
23. Sordi V. Mesenchymal stem cell homing capacity. Transplantation. 2009; 87(9 Suppl):S42-5.
24. Xu YX, Chen L, Wang R, et al. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses. 2008; 71 (3):390-393.
25. Bell GI, Broughton HC, Levac KD, et al. Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev. 2012; 21(1): 97-109.
Files
IssueVol 20 No 2 (2026) QRcode
SectionOriginal Article(s)
Keywords
Aging; Female; Insulin; Weight; Stem cell
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Astini W, Fitrianto AI, Utami A, Dwijayanti A, Dyanagiri Suyatna F, Winarto A, Boediono A. Human Wharton’s Jelly Mesenchymal Stem Cells Improve Insulin Levels and Reduce Weight Gain in Aging Female Rats. Int J Hematol Oncol Stem Cell Res. 2026;20(2):152-158.